DES PLAINES, Ill., Feb. 2, 2023 /PRNewswire/ -- Americaneagle.com, a family-owned, global digital agency, and ImmunoProfile, a medical diagnostics company, are proud to jointly announce the launch of ...
Existing monoclonal antibody development technologies, such as hybridoma technology, suffer from a loss of diversity due to cell fusion efficiency, and phage display technology creates antibodies ...
The immunoassay—a mainstay of life sciences and clinical diagnostic laboratories—detects and quantifies proteins and other kinds of molecules in complex samples, usually through the use of antibodies.
Advancement of therapeutic antibody discovery faces time and economic constraints. Merck R&D experts address this issue using Fluidic Sciences and Sphere Bio's microfluidic picodroplet technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results